PATENT CLAIM ANALYSIS

Application Number: 15935558
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "357000"]

Abstract:
The present invention relates to a new route of synthesis to obtain pharmaceutically acceptable Vismodegib. In addition, besides the synthesis also suitable pharmaceutical compositions and the use of the compound for the treatment of basal-cell carcinomas are disclosed.

Claim (Index 12):
The process according to  claim 7 , wherein the Grignard-reagent is 2,2,6,6-Tetramethylpiperidinylmagnesium chloride lithium chloride.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.24242
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10493314', '13141675', '12341281', '15147671', '13001201']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7679675671684264
- 35 USC 102 Novelty (BERT): 0.506461861720521
- Combined Prediction Score: 0.7418169966236359
- Mean Citation Score: 197.841746
- Max Citation Score: 211.89131
- Similarity Product: 130.20821744140923

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test